Raghava Life Sciences Private Limited

Raghava Life Sciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U74999TG2018PTC121553 Incorporated 02 January 2018 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹45.14 Cr
▼ 26% YoY
Net loss · FY 2025
₹8.52 Cr
Net margin -18.9%
EBITDA · FY 2025
₹5.18 Cr
EBITDA margin 11.5%
Authorised capital
₹50 Cr
Registered with MCA
Paid-up capital
₹40 Cr
Issued & subscribed
Open charges
₹52.18 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
322
Provident fund records

About Raghava Life Sciences Private Limited

Data last updated:

Raghava Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 January 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2018PTC121553. Its GSTIN is 36AAICR6963N1ZJ (Telangana).

The company has an authorised share capital of ₹50 Cr and a paid-up capital of ₹40 Cr. It is led by directors Sapni Reddy Ponguleti and Lohith Reddy Ponguleti.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹45.14 Cr, a decline of 26% compared to the previous year. For the same year it recorded a net loss of ₹8.52 Cr (net margin -18.9%) and EBITDA of ₹5.18 Cr (EBITDA margin 11.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 31% over five years.

The company has about 322 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Raghava Life. As per MCA filings, the company has open charges of ₹52.18 Cr on record. Court records list 6 cases involving the company, including 6 filed against it; 4 cases are pending. The company has 2 deals on record (1 funding round, 1 acquisition), with disclosed funding of ₹39.99 Cr; the latest was in September 2026. Its 6 peer companies in the Pharma industry (API Manufacturers, Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 4 smaller; the largest is Amara Labs Private Limited with revenue of ₹45.37 Cr.

Raghava Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0012852). For more details, the company can be reached via its website raghavalife.com.

Company details

CIN U74999TG2018PTC121553
Registration Number 121553
Incorporation Date 02 January 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0012852

Recognitions & Rankings of Raghava Life Sciences

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-TS-02-0012852

Contact details

Raghava Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is raghavalife.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Raghavapride H.No.8 – 2 – 603/1/27&28 Krishnapuramkrishnapuramstreet Roadno.10 Banjara, Hills, Hyderabad, Telangana, India – 500034
  • Industry
    Pharma, Drug Formulation & Development, API Manufacturers

To see the full contact details of Raghava Life Sciences Private Limited, buy the company report.

Comprehensive company report
Raghava Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Raghava Life Sciences operates one associated brand: Raghava Life. Each brand links to its own profile.

BrandDescriptionWebsite
Provides CRO and CDMO services for pharmaceutical APIs and intermediates globally.raghavalife.com

Business activity

The main business activity of Raghava Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Raghava Life Sciences Private Limited, buy the company report.

Financials of Raghava Life Sciences Private Limited

FY 2025 filings available

Raghava Life Sciences Private Limited reported revenue of ₹45.14 Cr (down 26% YoY) for FY 2025.

Revenue · FY 2025
₹45.14 Cr ▼ 26%
Net loss · FY 2025
₹8.52 Cr margin -18.9%
EBITDA · FY 2025
₹5.18 Cr margin 11.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 26%
3 years · compounded
▼ 3%
5 years · compounded
▲ 31%
EBITDA CAGR growth
1 year
▼ 24%
3 years · compounded
▼ 15%
5 years · compounded
▲ 26%

Revenue fell 26% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 31%. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹5.18 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹8.52 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin11.5%
Net Profit Margin-18.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Raghava Life Sciences Private Limited, buy the company report.

Board of directors of Raghava Life Sciences Private Limited

Raghava Life Sciences has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sapni Reddy PonguletiDirector02 Jan 20188 Years 9 MonthsCurrent
Lohith Reddy PonguletiDirector02 Jan 20188 Years 9 MonthsCurrent

Peer comparison

Raghava Life Sciences Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers, Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Amara Labs Private Limited₹45.37 Cr (FY 2021)173.0%Hyderabad, Telangana, India
Concord Drugs Limited₹45.26 Cr (FY 2025)1.0%Telangana, India
Raghava Life Sciences Private Limitedthis company₹45.14 Cr (FY 2025)-₹8.52 Cr-18.9%-26.0%322Hyderabad, Telangana, India
S.V.Chem Intermediates Private Limited₹44.99 Cr (FY 2025)-11.0%Thiruporur, Tamil Nadu, India
FR Chem Private Limited₹44.47 Cr (FY 2025)59.0%Ahmedabad, Gujarat, India
Unidrug Innovative Pharma Technologies Limited₹44.46 Cr (FY 2025)28.0%Indore, Madhya Pradesh, India
S.V.R. Laboratories Private Limited₹44.45 Cr (FY 2025)-3.0%Hyderabad, Telangana, India

To see the full peer comparison of Raghava Life Sciences Private Limited, buy the company report.

Auditor

Raghava Life Sciences Private Limited is audited by VAMSI SAI KRISHNA & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
VAMSI SAI KRISHNA & COFY 2023024528S

Shareholding

The shareholding of Raghava Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Raghava Life Sciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹52.18 Cr
Satisfied charges
None
Breakdown by lending institutions
Axis Bank Limited₹52.18 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Aug 2023100781235Axis Bank Limited₹9 LakhOpen
18 Dec 2021100532462Axis Bank Limited₹52.09 CrOpen

To see the full charge records of Raghava Life Sciences Private Limited, buy the company report.

Total charge records: 2 View all charges

Deals & funding

Raghava Life Sciences Private Limited has 2 deals on record (1 funding round, 1 acquisition), with disclosed funding of ₹39.99 Cr; the latest was in September 2026.

Total deals
2
Funding round
1
Acquisition
1
Disclosed funding
₹39.99 Cr

Deals on record (2 of 2)

WhenDealAmountParties
Sep 2026Acquisition₹135 CrBuyer: RPG Active Pharma Limited
Seller: Raghava Life Sciences Private Limited
Dec 2020Funding round₹39.99 CrInvestors: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Raghava Life Sciences Private Limited was last rated by Icra on 01 Feb 2021.

Rating agencyRated onRating
Icra01 Feb 2021

To see the full credit ratings and regulatory alerts of Raghava Life Sciences Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Raghava Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Raghava Life Sciences Private Limited has a workforce of 322 employees on its EPFO records as of Dec 19, 2024, across 1 active EPFO establishment.

Employee count
322
Active EPFO establishments
1
Employee growth
1.58%

GST

Raghava Life Sciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAICR6963N1ZJTelanganaActive19 Feb 2018

To see the full GST registrations and return filing status of Raghava Life Sciences Private Limited, buy the company report.

Recent activity

Raghava Life Sciences Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Lohith Reddy Ponguleti was appointed as Director on 02 Jan 2018.

AGM
Raghava Life Sciences Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Raghava Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited of Rs. 52.09 Cr registered on 18 Dec 2021 with Charge ID 100532462 was modified on 17 May 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.09 Cr with Charge ID 100781235 was registered on 24 Aug 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 52.09 Cr with Charge ID 100532462 was registered on 18 Dec 2021.
Appointed
Lohith Reddy Ponguleti was appointed as Director.
Appointed
Sapni Reddy Ponguleti was appointed as Director.
Incorporation
02 Jan 2018
Raghava Life Sciences Private Limited was registered on 02 Jan 2018 with Roc Hyderabad & aged 8 years 9 months as per MCA records.

Frequently asked questions

Raghava Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 January 2018 (8+ years old) and is registered under CIN U74999TG2018PTC121553.

Raghava Life Sciences has 2 current directors:

The latest financial statements of Raghava Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Raghava Life Sciences is 36AAICR6963N1ZJ, registered in Telangana.

The CIN (Corporate Identification Number) of Raghava Life Sciences is U74999TG2018PTC121553. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Raghava Life Sciences has 6 court cases on record: 6 filed against it. 4 are pending. Most are in the district courts.

Raghava Life Sciences was incorporated on 02 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.

Raghava Life Sciences has 2 deals on record (1 funding round, 1 acquisition), with disclosed funding of ₹39.99 Cr; the latest was in September 2026.

The peers of Raghava Life Sciences by revenue are Amara Labs Private Limited, Concord Drugs Limited, S.V.Chem Intermediates Private Limited, FR Chem Private Limited, Unidrug Innovative Pharma Technologies Limited and 1 more, all in the Pharma industry (API Manufacturers, Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Lohith Reddy Ponguleti was appointed as Director on 02 Jan 2018. Sapni Reddy Ponguleti was appointed as Director on 02 Jan 2018.

Yes, Raghava Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0012852).